Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie B Bernhardt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 18, 2020
Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administration and toxicity challengesMelanie B Bernhardt, Olga Militano, Lisa Honeyford, et al.
Journal of Pediatric Hematology/Oncology|November 8, 2016
Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for ToxicityJennifer H Foster, Melanie B Bernhardt, Patrick A Thompson, et al.
Pediatric Blood & Cancer|December 24, 2019
Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcomaElizabeth P Young, W Susan Cheng, Melanie B Bernhardt, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|February 28, 2012
Using improvement science to promote evidence-based practice in a childhood cancer and hematology centerMarilyn J Hockenberry, Kathy S McCarthy, Olga A Taylor, et al.
Pediatric Blood & Cancer|May 20, 2022
Distribution and frequency of tyrosine kinase inhibitor-associated long-term complications in children with chronic myeloid leukemiaElizabeth E Dong, Michael A Bruno, Jeffrey J Kim, et al.
Pediatric Blood & Cancer|July 2, 2023
Impact of undernutrition on the pharmacokinetics of chemotherapy in children with cancer: A systematic reviewSterre Schoon, Nthongase Makamo, Aniek Uittenboogaard, et al.
Scientific Reports|October 5, 2021
Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemiaJeremy M Schraw, J P Woodhouse, Melanie B Bernhardt, et al.
Pediatric Blood & Cancer|April 21, 2025
What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High-Dose Methotrexate Use in Pediatric MalignanciesZachary L Taylor, Tamara P Miller, Sarah G Board, et al.
British Journal of Cancer|June 26, 2025
Nutritional status, body composition and chemotherapy dosing in children and young people with cancer: a systematic review by the SIOP nutrition networkAmy L Lovell, Nthongase Makamo, Gareth J Veal, et al.
Clinical and Translational Science|July 28, 2023
Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.orgZachary L Taylor, Tamara P Miller, Ethan A Poweleit, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 18, 2020
Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administration and toxicity challengesMelanie B Bernhardt, Olga Militano, Lisa Honeyford, et al.
Journal of Pediatric Hematology/Oncology|November 8, 2016
Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for ToxicityJennifer H Foster, Melanie B Bernhardt, Patrick A Thompson, et al.
Pediatric Blood & Cancer|December 24, 2019
Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcomaElizabeth P Young, W Susan Cheng, Melanie B Bernhardt, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|February 28, 2012
Using improvement science to promote evidence-based practice in a childhood cancer and hematology centerMarilyn J Hockenberry, Kathy S McCarthy, Olga A Taylor, et al.
Pediatric Blood & Cancer|May 20, 2022
Distribution and frequency of tyrosine kinase inhibitor-associated long-term complications in children with chronic myeloid leukemiaElizabeth E Dong, Michael A Bruno, Jeffrey J Kim, et al.
Pediatric Blood & Cancer|July 2, 2023
Impact of undernutrition on the pharmacokinetics of chemotherapy in children with cancer: A systematic reviewSterre Schoon, Nthongase Makamo, Aniek Uittenboogaard, et al.
Scientific Reports|October 5, 2021
Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemiaJeremy M Schraw, J P Woodhouse, Melanie B Bernhardt, et al.
Pediatric Blood & Cancer|April 21, 2025
What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High-Dose Methotrexate Use in Pediatric MalignanciesZachary L Taylor, Tamara P Miller, Sarah G Board, et al.
British Journal of Cancer|June 26, 2025
Nutritional status, body composition and chemotherapy dosing in children and young people with cancer: a systematic review by the SIOP nutrition networkAmy L Lovell, Nthongase Makamo, Gareth J Veal, et al.
Clinical and Translational Science|July 28, 2023
Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.orgZachary L Taylor, Tamara P Miller, Ethan A Poweleit, et al.
Pageof 2